Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 4, 2013, Pages 553-564

  Talbot, Julie ^a,b,c,d,e   Brion, Régis ^a,b,c,d,e   Picarda, Gaëlle ^a,b,c,d,e   Amiaud, Jérome ^a,b,c,d,e   Chesneau, Julie ^a,b,c,d,e   Bougras, Gwenola ^a,b,c,d,e   Stresing, Verena ^a,b,c,d,e   Tirode, Franck ^f   Heymann, Dominique ^a,b,c,d,e   Redini, Françoise ^a,b,c,d,e   Verrecchia, Franck ^a,b,c,d,e  

^a LUNAM Universite   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d HÔTEL DIEU   (France)

^e Equipe LIGUE Nationale Contre le Cancer 2012   (France)

^f INSTITUT CURIE   (France)

Author keywords

Connexin43; Ewing's sarcoma; EWS FLI1; Osteolysis; Tumor growth

Indexed keywords

CONNEXIN 43; CONNEXIN 45; MESSENGER RNA; PROTEIN P27; RETINOBLASTOMA PROTEIN; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; CELL CYCLE G0 PHASE; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; EWING SARCOMA; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GAP JUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR GROWTH; WESTERN BLOTTING;

BONE NEOPLASMS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; CONNEXIN 43; EMBRYONIC STEM CELLS; GAP JUNCTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS, FUSION; OSTEOLYSIS; PROTO-ONCOGENE PROTEIN C-FLI-1; RNA-BINDING PROTEIN EWS; SARCOMA, EWING;

EID: 84873298227     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.01.001     Document Type: Article

References (57)

1. Bleyer A., Barr R., Hayes-Lattin B., Thomas D., Ellis C., Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat. Rev. Cancer 2008, 8:288-298.
2. Balamuth N.J., Womer R.B. Ewing's sarcoma. Lancet Oncol. 2010, 11:184-192.
3. Jedlicka P. Ewing sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. Int. J. Clin. Exp. Pathol. 2010, 3:338-347.
4. Taylor R., Knowles H.J., Athanasou N.A. Ewing sarcoma cells express RANKL and support osteoclastogenesis. J. Pathol. 2011, 225:195-202.
5. Turc-Carel C., Aurias A., Mugneret F., Lizard S., Sidaner I., Volk C., Thiery J.P., Olschwang S., Philip I., Berger M.P. Chromosomes in Ewing's sarcoma I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 1988, 32:229-238.
6. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., de Jong P., Rouleau G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992, 359:162-165.
7. Riggi N., Stamenkovic I. The biology of Ewing sarcoma. Cancer Lett. 2007, 254:1-10.
8. Tirode F., Laud-Duval K., Prieur A., Delorme B., Charbord P., Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007, 11:421-429.
9. Sosinsky G.E., Nicholson B.J. Structural organization of gap junction channels. Biochim. Biophys. Acta 2005, 1711:99-125.
10. Kumar N.M., Gilula N.B. The gap junction communication channel. Cell 1996, 84:381-388.
11. Tacheau C., Fontaine J., Loy J., Mauviel A., Verrecchia F. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways. J. Cell. Physiol. 2008, 217:759-768.
12. Tacheau C., Laboureau J., Mauviel A., Verrecchia F. TNF-alpha represses connexin43 expression in HaCat keratinocytes via activation of JNK signaling. J. Cell. Physiol. 2008, 216:438-444.
13. Verrecchia F., Duthe F., Duval S., Duchatelle I., Sarrouilhe D., Herve J.C. ATP counteracts the rundown of gap junctional channels of rat ventricular myocytes by promoting protein phosphorylation. J. Physiol. (Lond.) 1999, 516(Pt 2):447-459.
14. Verrecchia F., Hervé J. Reversible inhibition of gap junctional communication by tamoxifen in cultured cardiac myocytes. Pflugers Arch. 1997, 434:113-116.
15. Pluciennik F., Verrecchia F., Bastide B., Hervé J.C., Joffre M., Délèze J. Reversible interruption of gap junctional communication by testosterone propionate in cultured Sertoli cells and cardiac myocytes. J. Membr. Biol. 1996, 149:169-177.
16. S.-S. Zhang, R.M. Shaw, Multilayered regulation of cardiac ion channels, Biochim. Biophys. Acta (in press), http://dx.doi.org/10.1016/j.bbamcr.2012.10.020.
17. Firestone G.L., Kapadia B.J. Minireview: regulation of gap junction dynamics by nuclear hormone receptors and their ligands. Mol. Endocrinol. 2012, 26:1798-1807.
18. Matsuuchi L., Naus C.C. Gap junction proteins on the move: connexins, the cytoskeleton and migration. Biochim. Biophys. Acta 2013, 1828:94-108.
19. Naus C.C.G. Gap junctions and tumour progression. Can. J. Physiol. Pharmacol. 2002, 80:136-141.
20. Mesnil M., Crespin S., Avanzo J.-L., Zaidan-Dagli M.-L. Defective gap junctional intercellular communication in the carcinogenic process. Biochim. Biophys. Acta 2005, 1719:125-145.
21. Cronier L., Crespin S., Strale P.-O., Defamie N., Mesnil M. Gap junctions and cancer: new functions for an old story. Antioxid. Redox Signal. 2009, 11:323-338.
22. Krutovskikh V.A., Troyanovsky S.M., Piccoli C., Tsuda H., Asamoto M., Yamasaki H. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 2000, 19:505-513.
23. Momiyama M., Omori Y., Ishizaki Y., Nishikawa Y., Tokairin T., Ogawa J., Enomoto K. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Sci. 2003, 94:501-507.
24. Goodenough D.A., Paul D.L. Beyond the gap: functions of unpaired connexon channels. Nat. Rev. Mol. Cell Biol. 2003, 4:285-294.
25. Kausalya P.J., Phua D.C.Y., Hunziker W. Association of ARVCF with zonula occludens (ZO)-1 and ZO-2: binding to PDZ-domain proteins and cell-cell adhesion regulate plasma membrane and nuclear localization of ARVCF. Mol. Biol. Cell 2004, 15:5503-5515.
26. Giepmans B.N.G. Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 2004, 62:233-245.
27. Civitelli R. Cell-cell communication in the osteoblast/osteocyte lineage. Arch. Biochem. Biophys. 2008, 473:188-192.
28. Bustin S.A. Why the need for qPCR publication guidelines? - The case for MIQE. Methods 2010, 50:217-226.
29. De Leon J.R., Buttrick P.M., Fishman G.I. Functional analysis of the connexin43 gene promoter in vivo and in vitro. J. Mol. Cell. Cardiol. 1994, 26:379-389.
30. Kimura K., Teranishi S., Nishida T. Establishment of human corneal epithelial cells stably expressing human connexin43. Exp. Eye Res. 2010, 90:4-9.
31. Goldberg G.S., Bechberger J.F., Naus C.C. A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques 1995, 18:490-497.
32. Ziambaras K., Lecanda F., Steinberg T.H., Civitelli R. Cyclic stretch enhances gap junctional communication between osteoblastic cells. J. Bone Miner. Res. 1998, 13:218-228.
33. Heymann D., Ory B., Blanchard F., Heymann M.-F., Coipeau P., Charrier C., Couillaud S., Thiery J.P., Gouin F., Redini F. Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone 2005, 37:74-86.
34. Valiunas V., Doronin S., Valiuniene L., Potapova I., Zuckerman J., Walcott B., Robinson R.B., Rosen M.R., Brink P.R., Cohen I.S. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol. (Lond.) 2004, 555:617-626.
35. Naus C.C., Bechberger J.F., Caveney S., Wilson J.X. Expression of gap junction genes in astrocytes and C6 glioma cells. Neurosci. Lett. 1991, 126:33-36.
36. Jamieson S., Going J.J., D'Arcy R., George W.D. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J. Pathol. 1998, 184:37-43.
37. Saunders M.M., Seraj M.J., Li Z., Zhou Z., Winter C.R., Welch D.R., Donahue H.J. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res. 2001, 61:1765-1767.
38. May W.A., Gishizky M.L., Lessnick S.L., Lunsford L.B., Lewis B.C., Delattre O., Zucman J., Thomas G., Denny C.T. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:5752-5756.
39. Lessnick S.L., Braun B.S., Denny C.T., May W.A. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 1995, 10:423-431.
40. Bailly R.A., Bosselut R., Zucman J., Cormier F., Delattre O., Roussel M., Thomas G., Ghysdael J. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 1994, 14:3230-3241.
41. Fukuma M., Okita H., Hata J.-I., Umezawa A. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene 2003, 22:1-9.
42. Wai D.H., Schaefer K.-L., Schramm A., Korsching E., Van Valen F., Ozaki T., Boecker W., Schweigerer L., Dockhorn-Dworniczak B., Poremba C. Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int. J. Oncol. 2002, 20:441-451.
43. Zwerner J.P., May W.A. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene 2001, 20:626-633.
44. Nakatani F., Tanaka K., Sakimura R., Matsumoto Y., Matsunobu T., Li X., Hanada M., Okada T., Iwamoto Y. Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein. J. Biol. Chem. 2003, 278:15105-15115.
45. Dauphinot L., De Oliveira C., Melot T., Sevenet N., Thomas V., Weissman B.E., Delattre O. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene 2001, 20:3258-3265.
46. Hahm K.B., Cho K., Lee C., Im Y.H., Chang J., Choi S.G., Sorensen P.H., Thiele C.J., Kim S.J. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat. Genet. 1999, 23:222-227.
47. Prieur A., Tirode F., Cohen P., Delattre O. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 2004, 24:7275-7283.
48. Lessnick S.L., Ladanyi M. Molecular pathogenesis of ewing sarcoma: new therapeutic and transcriptional targets. Annu. Rev. Pathol. 2012, 7:145-159.
49. Czyz J. The stage-specific function of gap junctions during tumourigenesis. Cell. Mol. Biol. Lett. 2008, 13:92-102.
50. Budunova I.V., Williams G.M. Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol. Toxicol. 1994, 10:71-116.
51. Mesnil M., Yamasaki H. Cell-cell communication and growth control of normal and cancer cells: evidence and hypothesis. Mol. Carcinog. 1993, 7:14-17.
52. Zhang Y.W., Morita I., Ikeda M., Ma K.W., Murota S. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene 2001, 20:4138-4149.
53. Halvorson K.G., Sevcik M.A., Ghilardi J.R., Rosol T.J., Mantyh P.W. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. Clin. J. Pain 2006, 22:587-600.
54. Grano M., Mori G., Minielli V., Cantatore F.P., Colucci S., Zallone A.Z. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts. Biochem. Biophys. Res. Commun. 2000, 270:1097-1100.
55. Guise T.A., Yin J.J., Taylor S.D., Kumagai Y., Dallas M., Boyce B.F., Yoneda T., Mundy G.R. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 1996, 98:1544-1549.
56. Pfeilschifter J., Mundy G.R. Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:2024-2028.
57. Naus C.C., Laird D.W. Implications and challenges of connexin connections to cancer. Nat. Rev. Cancer 2010, 10:435-441.